Presentation Information

[AL22]Invention of a SARS-CoV-2 RNA vaccine using DS-LNP-mRNA technology

○Nao Jonai1, Natsuki Tanaka2, Takako Niwa3, Takashi Suzuki4 (1. Vaccine Research Laboratories, Daiichi Sankyo Co., LTD., 2. R&D Portfolio Planning Department, Daiichi Sankyo Co., LTD., 3. Modality Research Laboratories I, Daiichi Sankyo Co., LTD., 4. Bioprocess Technology Research Laboratories II, Daiichi Sankyo Co., LTD.)